{
  "patient_id": "jason_r",
  "extraction_metadata": {
    "extracted_from": ["01_Prior_Auth_Request_Form.pdf", "02_Laboratory_Results.pdf", "03_MRI_Spine_Report.pdf"],
    "extraction_date": "2026-02-17",
    "extraction_method": "clinical_document_extraction"
  },

  "demographics": {
    "first_name": "Jason",
    "last_name": "Rivera",
    "date_of_birth": "1986-05-10",
    "age": 39,
    "gender": "Male",
    "ethnicity": "Hispanic",
    "address": { "street": "4450 N 32nd Street", "city": "Phoenix", "state": "AZ", "zip": "85018" },
    "phone": "602-555-0321",
    "mrn": "JASON_R",
    "source_document": "01_Prior_Auth_Request_Form.pdf"
  },

  "insurance": {
    "primary": {
      "payer_name": "BCBS",
      "payer_id": "BCBS_AZ",
      "plan_name": "Blue Cross Blue Shield of Arizona PPO",
      "plan_type": "PPO",
      "member_id": "BCBS567891234",
      "group_number": "AZ-PPO-2024",
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    }
  },

  "prescriber": {
    "name": "Dr. Steven Ortiz",
    "credentials": "MD, FACR",
    "npi": "1567890123",
    "specialty": "Rheumatology",
    "practice_name": "Arizona Arthritis & Rheumatology Associates",
    "address": { "street": "2001 W Camelback Road, Suite 150", "city": "Phoenix", "state": "AZ", "zip": "85015" },
    "phone": "602-555-1500",
    "fax": "602-555-1501",
    "source_document": "01_Prior_Auth_Request_Form.pdf"
  },

  "medication_request": {
    "medication_name": "Infliximab",
    "brand_name": "Inflectra",
    "generic_name": "infliximab-dyyb",
    "j_code": "Q5103",
    "product_type": "preferred_biosimilar",
    "dose": "5mg/kg",
    "route": "Intravenous infusion",
    "frequency": { "induction": "Weeks 0, 2, 6", "maintenance": "Every 6 weeks" },
    "duration_requested": "12 months initial authorization",
    "quantity_requested": "4 infusions",
    "site_of_care": "Outpatient infusion center",
    "start_date_requested": "2026-03-05",
    "diagnosis": "Ankylosing spondylitis",
    "icd10_code": "M45.9",
    "source_document": "01_Prior_Auth_Request_Form.pdf"
  },

  "diagnoses": [
    {
      "rank": "primary",
      "icd10_code": "M45.9",
      "description": "Ankylosing spondylitis of unspecified sites in spine",
      "status": "active",
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    },
    {
      "rank": "secondary",
      "icd10_code": "M07.3",
      "description": "Other psoriatic arthropathy",
      "status": "active",
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    }
  ],

  "disease_activity": {
    "assessment_date": "2026-02-05",
    "basdai_score": 6.5,
    "basdai_interpretation": "High disease activity (BASDAI >=4)",
    "basfi_score": 5.8,
    "basfi_interpretation": "Moderate-to-significant functional impairment",
    "asdas_crp": 3.2,
    "asdas_interpretation": "High disease activity (ASDAS 2.1-3.5)",
    "disease_severity": "severe",
    "hla_b27": "Positive",
    "peripheral_arthritis": true,
    "peripheral_joints_affected": ["bilateral knees", "left ankle"],
    "source_documents": ["01_Prior_Auth_Request_Form.pdf", "03_MRI_Spine_Report.pdf"]
  },

  "clinical_history": {
    "chief_complaint": "Severe inflammatory back pain with peripheral joint involvement, progressive spinal fusion despite NSAIDs",
    "history_of_present_illness": "39-year-old Hispanic male with HLA-B27 positive AS diagnosed 2019, complicated by peripheral arthritis in bilateral knees and left ankle. BASDAI 6.5, ASDAS-CRP 3.2. MRI shows active sacroiliitis with extensive bone marrow edema and new syndesmophyte formation at L3-L4. Spinal mobility severely reduced (modified Schober <3cm, chest expansion <2cm). Failed 2 NSAIDs at maximum dose (diclofenac 150mg/day for 3 months, meloxicam 15mg/day for 4 months). Sulfasalazine tried for peripheral component with minimal benefit. Patient is a firefighter, currently on disability due to inability to perform physical duties. Onset of anterior uveitis 6 months ago (resolved with topical steroids) supports systemic TNF-driven disease.",
    "source_document": "01_Prior_Auth_Request_Form.pdf"
  },

  "prior_treatments": [
    {
      "medication_name": "Diclofenac",
      "drug_class": "NSAID",
      "dose": "75mg BID (150mg daily)",
      "start_date": "2024-01-01",
      "end_date": "2024-04-01",
      "duration_weeks": 13,
      "outcome": "inadequate_response",
      "outcome_description": "Persistent high disease activity (BASDAI >6) despite maximum dose for 3 months",
      "adequate_trial": true,
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    },
    {
      "medication_name": "Meloxicam",
      "drug_class": "NSAID (COX-2 preferential)",
      "dose": "15mg daily",
      "start_date": "2024-05-01",
      "end_date": "2024-09-01",
      "duration_weeks": 17,
      "outcome": "inadequate_response",
      "outcome_description": "Minimal improvement. BASDAI remained >6. Progressive radiographic changes on follow-up X-ray.",
      "adequate_trial": true,
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    },
    {
      "medication_name": "Sulfasalazine",
      "drug_class": "csDMARD",
      "dose": "2g daily",
      "start_date": "2024-10-01",
      "end_date": "2025-06-01",
      "duration_weeks": 35,
      "outcome": "inadequate_response",
      "outcome_description": "Minimal improvement in peripheral arthritis. No effect on axial disease as expected per ASAS guidelines.",
      "adequate_trial": true,
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    }
  ],

  "laboratory_results": {
    "collection_date": "2026-02-03",
    "ordering_provider": "Dr. Steven Ortiz",
    "facility": "Banner Health Clinical Lab",
    "report_status": "FINAL",
    "source_document": "02_Laboratory_Results.pdf",
    "panels": {
      "cbc": {
        "panel_name": "Complete Blood Count (CBC)",
        "results": [
          {"test": "WBC", "value": 9.0, "unit": "x10^9/L", "reference_range": "4.5-11.0", "flag": null},
          {"test": "Hemoglobin", "value": 14.2, "unit": "g/dL", "reference_range": "13.5-17.5", "flag": null},
          {"test": "Platelets", "value": 275, "unit": "x10^9/L", "reference_range": "150-400", "flag": null}
        ]
      },
      "inflammatory_markers": {
        "panel_name": "Inflammatory Markers",
        "results": [
          {"test": "CRP", "value": 18, "unit": "mg/L", "reference_range": "0-5", "flag": "H"},
          {"test": "ESR", "value": 30, "unit": "mm/hr", "reference_range": "0-15", "flag": "H"}
        ]
      },
      "hla_typing": {
        "panel_name": "HLA Typing",
        "results": [
          {"test": "HLA-B27", "value": "Positive", "reference_range": "Negative", "flag": "Positive"}
        ]
      },
      "hepatic_panel": {
        "panel_name": "Hepatic Panel",
        "results": [
          {"test": "ALT", "value": 20, "unit": "U/L", "reference_range": "7-56", "flag": null},
          {"test": "Creatinine", "value": 0.9, "unit": "mg/dL", "reference_range": "0.7-1.3", "flag": null}
        ]
      }
    },
    "interpretation": "Active AS with elevated CRP (18) and ESR (30). HLA-B27 positive. CBC and metabolic panel normal."
  },

  "pre_biologic_screening": {
    "status": "COMPLETE",
    "tuberculosis_screening": { "status": "COMPLETE", "test_performed": "QuantiFERON-TB Gold Plus", "result": "Negative", "cleared_for_biologic": true },
    "hepatitis_b_screening": { "status": "COMPLETE", "interpretation": "HBV negative with immunity from vaccination", "cleared_for_biologic": true },
    "hepatitis_c_screening": { "status": "COMPLETE", "result": "Non-reactive", "cleared_for_biologic": true }
  },

  "pa_criteria_assessment": {
    "diagnosis_confirmed": { "met": true, "evidence": "HLA-B27 positive AS with MRI-confirmed active sacroiliitis and syndesmophytes" },
    "disease_severity_documented": { "met": true, "evidence": "BASDAI 6.5, ASDAS-CRP 3.2, CRP 18, history of uveitis, progressive radiographic changes" },
    "conventional_therapy_failed": {
      "met": true,
      "therapies_tried": [
        {"medication": "Diclofenac", "outcome": "inadequate_response", "duration_adequate": true},
        {"medication": "Meloxicam", "outcome": "inadequate_response", "duration_adequate": true}
      ]
    },
    "step_therapy_satisfied": { "met": true, "evidence": "Failed >=2 NSAIDs at maximum dose per ASAS/EULAR guidelines" },
    "pre_biologic_screening_complete": { "met": true },
    "fda_approved_indication": { "met": true, "indication": "Active ankylosing spondylitis" }
  },

  "overall_pa_readiness": {
    "status": "READY_FOR_SUBMISSION",
    "all_clinical_criteria_met": true,
    "recommendation": "Strong case. HLA-B27 positive AS with high disease activity, progressive spinal fusion, extra-articular manifestation (uveitis), and NSAID failure. Submit immediately."
  }
}
